Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy

Cited by (405)

Items 101–200 of 405

1. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy
   Sung Hoon Yu, Jun Goo Kang, Chul Sik Kim, Sung‐Hee Ihm, Moon Gi Choi, Hyung Joon Yoo, Seong Jin Lee · 2017 · Thyroid
2. Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves’ Orbitopathy
   Amin Bennedjaï, Nacim Bouheraoua, Marc Gatfossé, L Du Pasquier-Fediaevsky, Marie‐Hélène Errera, M. Tazartès, Vincent Michel Borderie, Quentin Hennocq, Azeddine Dellal, Sébastien Rivière et al. · 2020 · Ocular Immunology and Inflammation
3. Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy
   Yoko Kaichi, Keizo Tanitame, Hideki Itakura, Haruya Ohno, Masayasu Yoneda, Yuji K. Takahashi, Yuji Akiyama, Kazuo Awai · 2016 · American Journal of Neuroradiology
4. Retinal vascularity, nerve fiber, and ganglion cell layer thickness in thyroid eye disease on optical coherence tomography angiography
   Tarjani Vivek Dave, Srujana Laghmisetty, Gayatri Krishnamurthy, Kavya Madhuri Bejjanki, Anasua Ganguly, Ganesh Babu Jonnadula, Vivek Pravin Dave, Rajeev Reddy Pappuru · 2020 · Orbit
5. Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination
   Ilaria Muller, Dario Consonni, Erica Crivicich, Francesco Di Marco, Nicola Currò, Mario Salvi · 2023 · The Journal of Clinical Endocrinology & Metabolism
6. Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease
   Nicole Quah Qin Xian, Ahmed Alnahrawy, Rashmi Akshikar, Vickie Lee · 2021 · Clinical ophthalmology
7. Predicting the Course of Graves’ Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional Bioassay
   Svenja Philipp, Anja Katrin Eckstein, Mareile Stöhr, Michael Oeverhaus, Simon D. Lytton, Mareike Horstmann, Denise Zwanziger, Lars Christian Möller, Achim Stark, Dagmar Führer‐Sakel et al. · 2021 · Hormone and Metabolic Research
8. Is modified clinical activity score an accurate indicator of diplopia progression in Graves’ orbitopathy patients?
   Ji Won Kim, Young Jun Woo, Jin Sook Yoon · 2016 · Endocrine Journal
9. Medical management of thyroid eye disease
   Dawn D. Yang, Mithra O. Gonzalez, Vikram D. Durairaj · 2010 · Saudi Journal of Ophthalmology
10. Customized Minimally Invasive Orbital Decompression Surgery Improves Lower Eyelid Retraction and Contour in Thyroid Eye Disease
    Allan Christian Pieroni Gonçalves, Shivani Gupta, Mário Luiz Ribeiro Monteiro, Raymond S. Douglas · 2016 · Ophthalmic Plastic and Reconstructive Surgery
11. Serum concentrations of HGF and IL-8 in patients with active Graves’ orbitopathy before and after methylprednisolone therapy
    Mariusz Nowak, Lucyna Siemińśka, Jacek Karpe, Bogdan Marek, Beata Kos‐Kudła, Dariusz Kajdaniuk · 2015 · Journal of Endocrinological Investigation
12. Evaluation of Corneal Biomechanical Properties in Patients With Thyroid Eye Disease Using Ocular Response Analyzer
    Sasan Moghimi, Mona Safizadeh, Mehdi Mazloumi, Hamid Hosseini, Zakieh Vahedian, Mohammad Taher Rajabi · 2015 · Journal of Glaucoma
13. The impact of bodily change on social behaviour in patients with Thyroid‐Associated Ophthalmopathy
    Annesofie Lunde Jensen, Ingegerd Harder · 2010 · Scandinavian Journal of Caring Sciences
14. Safety and Efficacy of Combined Immunosuppression and Orbital Radiotherapy in Thyroid-Related Restrictive Myopathy: Two-Center Experience
    Nikolaos T. Chalvatzis, Argyrios K. Tzamalis, Georgios K. Kalantzis, Nabil El‐Hindy, Stavros A. Dimitrakos, Michael J. Potts · 2014 · European Journal of Ophthalmology
15. Relation between Graves’ orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions*
    Maria Laura Tanda, Adriana Lai, Luigi Bartalena · 2008 · Clinical Endocrinology
16. Transnasal endoscopic orbital decompression: 15-year clinical experience in Southern Taiwan
    Yun‐Ying She, Chao‐Chuan Chi, Sau‐Tung Chu · 2012 · Journal of the Formosan Medical Association
17. When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves’ disease be discontinued?
    Suyeon Park, Eyun Song, Hye‐Seon Oh, Mijin Kim, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Doo Man Kim, Won Bae Kim · 2019 · Endocrine
18. The EUGOGO Consensus Statement on the Management of Graves' Orbitopathy: Equally Applicable to North American Clinicians and Patients
    Rebecca S. Bahn · 2008 · Thyroid
19. Thyroid Volume and Severity of Graves' Orbitopathy
    Maria Antonietta Profilo, Eleonora Sisti, Claudio Marcocci, Paolo Vitti, Aldo Pinchera, Marco Nardi, Roberto Rocchi, Francesco Latrofa, Francesca Menconi, Maria Antonietta Altea et al. · 2012 · Thyroid
20. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients
    Byeong Jae Son, Sang Yeul Lee, Jin Sook Yoon · 2014 · Canadian Journal of Ophthalmology
21. Are Ethnicity, Social Grade, and Social Deprivation Associated With Severity of Thyroid-Associated Ophthalmopathy?
    Matthew R. Edmunds, Julie Huntbach, Omar M. Durrani · 2014 · Ophthalmic Plastic and Reconstructive Surgery
22. Prospective, systematically recorded mycophenolate safety data in Graves’ orbitopathy
    M. Riedl, Annegret Kuhn, Irene Krämer, E. W. Kolbe, George Jean Kahaly · 2016 · Journal of Endocrinological Investigation
23. Proteomics Screening of Differentially Expressed Cytokines in Tears of Patients with Graves’ Ophthalmopathy
    Ronghua Song, Bin Wang, Qiuming Yao, Qian Li, Xi Jia, Jin‐an Zhang · 2019 · Endocrine Metabolic & Immune Disorders - Drug Targets
24. Peripapillary structural and microvascular alterations in early dysthyroid optic neuropathy
    Yufei Wu, Qiaoli Yang, Liujun Ding, Yunhai Tu, Xiaoyu Deng, Yan Yang, Meixiao Shen, Qinkang Lu, Fan Lü, Qi Chen · 2022 · Eye and Vision
25. B-Cell Targeted Therapy With Rituximab for Thyroid Eye Disease: Closer to the Clinic
    Sunny Yu Shen, Anita Sook Yee Chan, Petros Paul Sfikakis, Andrea Low Hsiu Ling, Εfstathios T. Detorakis, Kostas G. Boboridis, Ioannis Mavrikakis · 2012 · Survey of Ophthalmology
26. Ocular surface changes in Graves’ ophthalmopathy
    Rou Sun, Xianqun Fan · 2021 · International Journal of Ophthalmology
27. Pediatric Thyroid Eye Disease—The Singapore Experience
    N.C. Lim, Shantha Amrith, Gangadhara Sundar · 2013 · Orbit
28. What Is the Aim of Immunosuppressive Treatment in Patients With Graves’ Orbitopathy?
    Morgan Yang, Wilmar M. Wiersinga, Maarten R. Soeters, Maarten P. Mourits · 2014 · Ophthalmic Plastic and Reconstructive Surgery
29. Review of the treatment of Graves’ ophthalmopathy: The role of the new radiation techniques
    Iñigo San Miguel, Meritxell Arenas, Ruth Carmona, Joaquín Rutllán, Medina Rivero Fj, Pedro C. Lara · 2017 · Saudi Journal of Ophthalmology
30. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves’ Ophthalmopathy
    Sita Virakul, Poorichaya Somparn, Trairak Pisitkun, Peter J. van der Spek, Virgil A. S. H. Dalm, Dion A. Paridaens, P. Martin van Hagen, Nattiya Hirankarn, Tanapat Palaga, Willem A. Dik · 2021 · Frontiers in Endocrinology
31. High-Dose Intravenous Glucocorticoid Therapy for Graves' Ophthalmopathy: Where Are We Now?
    Rebecca S. Bahn · 2012 · Thyroid
32. An ensemble deep learning diagnostic system for determining Clinical Activity Scores in thyroid-associated ophthalmopathy: integrating multi-view multimodal images from anterior segment slit-lamp photographs and facial images
    Chunfang Yan, Zhaoxia Zhang, Guanghua Zhang, Han Liu, Ruiqi Zhang, Guiqin Liu, Jing Rao, Weihua Yang, Bin Sun · 2024 · Frontiers in Endocrinology
33. Evaluation of medical and surgical decompression in patients with dysthyroid optic neuropathy
    Aylin Garip Kuebler, Caroline Wiecha, Lukas Reznicek, Annemarie Klingenstein, Kathrin Halfter, Siegfried Georg Priglinger, Christoph R. Hintschich · 2020 · Eye
34. Rituximab for thyroid-associated ophthalmopathy
    Swan Kang, Shirin Hamed Azzam, Neda Minakaran, Daniel G. Ezra · 2022 · Cochrane Database of Systematic Reviews
35. Management of Graves' Disease
    Becky Muldoon, Vinh Q. Mai, Henry B. Burch · 2014 · Endocrinology and Metabolism Clinics of North America
36. Role of Magnetic Resonance Imaging in the Assessment of Active Thyroid-Associated Ophthalmopathy Patients with Long Disease Duration
    Mengxi Zhou, Liyun Shen, Jiao Qin, Lei Ye, Yulin Zhou, Wei Zhu, Weiqing Wang, Shu Wang · 2019 · Endocrine Practice
37. Hypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves’ thyrotoxicosis and ophthalmopathy
    Stelios K. Tigas, Petros Papachilleos, Nikolaos Ligkros, Maria Andrikoula, Agathocles A. Tsatsoulis · 2011 · HORMONES
38. Inherited Disorders of Thyroid Hormone Metabolism Defect Caused by the Dysregulation of Selenoprotein Expression
    Kyu Won Lee, Yoochan Shin, Sungahn Lee, Sihoon Lee · 2022 · Frontiers in Endocrinology
39. Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort
    Meihua Jin, Ahreum Jang, Chae A Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Won Gu Kim · 2023 · European Thyroid Journal
40. Prevalence, Incidence, and Clinical Characteristics of Thyroid Eye Disease in Japan
    Natsuko Watanabe, Ai Kozaki, Kosuke Inoue, Hiroto Narimatsu, Masahiko Shinohara, Michael LoPresti · 2023 · Journal of the Endocrine Society
41. Proptosis Reduction by Clinical vs Radiological Modalities and Medial vs Inferomedial Approaches
    Suman Shumsher Thapa, Ashok Kumar Gupta, Amod Gupta, V. Gupta, Pinaki R Dutta, Ramandeep Singh Virk · 2015 · JAMA Otolaryngology–Head & Neck Surgery
42. Effect of orbital decompression on dysthyroid optic neuropathy
    Qiao-Wen Liang, Huasheng Yang, Wenjing Luo, Jianfeng He, Yi Du · 2019 · Medicine
43. Intravenous glucocorticoids therapy in the treatment of Graves’ ophthalmopathy: a systematic review and Meta-analysis
    Li-Quan Zhao · 2019 · International Journal of Ophthalmology
44. Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves’ ophthalmopathy
    Aleksander Kuś, Konrad Szymański, Beata Jurecka‐Lubieniecka, Edyta Pawlak, Dorota Kula, Piotr Miśkiewicz, Marek Bolanowski, Rafał Płoski, Artur Tadeusz Bossowski, Jacek Daroszewski et al. · 2016 · Journal of Human Genetics
45. Diffusion-weighted magnetic resonance imaging of extraocular muscles in patients with Grave's ophthalmopathy using turbo field echo with diffusion-sensitized driven-equilibrium preparation
    Akio Hiwatashi, Osamu Togao, Koji Yamashita, Kazufumi Kikuchi, Daichi Momosaka, Hiroshi Honda · 2018 · Diagnostic and Interventional Imaging
46. Choroidal vascularity index in thyroid eye disease: comparison with controls and application in diagnosing non-inflammatory active disease
    Tarjani Vivek Dave, Ganesh Babu Jonnadula, Prashanthi Lanka, Ramya Natarajan, Vivek Pravin Dave · 2022 · Orbit
47. Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review
    Kourosh Shahraki, Vida Ilkhani Pak, Amin Najafi, Kianoush Shahraki, Paria Ghasemi Boroumand, Roghayeh Sheervalilou · 2023 · Non-coding RNA Research
48. A Preliminary Evaluation of the Diagnostic Performance of a Smartphone-Based Machine Learning-Assisted System for Evaluation of Clinical Activity Score in Digital Images of Thyroid-Associated Orbitopathy
    Kyubo Shin, Ho-Kyung Choung, Min Joung Lee, Jongchan Kim, Gyeong Min Lee, Seongmi Kim, Jae Hyuk Kim, Richul Oh, Jisun Park, Sang Muk Lee et al. · 2024 · Thyroid
49. Reduction of Orbital Inflammation following Decompression for Thyroid-Related Orbitopathy
    Sang-Rog Oh, Jonathan D. Tung, Ayelet Priel, Leah Levi, David B. Granet, Bobby S. Korn, Don O. Kikkawa · 2013 · BioMed Research International
50. The tear cytokine profile in patients with active Graves’ orbitopathy
    Morgan Yang, Yvonne Chung, Stephanie Shuang Lang, Nobuyo Yawata, Lay Leng Seah, Audrey L. G. Looi · 2017 · Endocrine
51. Comparison of two regimens for patients with thyroid‑associated ophthalmopathy receiving intravenous methyl prednisolone: A single center prospective randomized trial
    Panwei Mu, Xixiang Tang, Yina Wang, Shuo Lin, Manman Wang, Qiong-Li Yin, Jiong Shu, Bilian Zhu, Jing-Ren Li, Li Zhou et al. · 2020 · Experimental and Therapeutic Medicine
52. A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency
    Aylin Garip Kuebler, Kathrin Halfter, Lukas Reznicek, Annemarie Klingenstein, Siegfried Georg Priglinger, Günther Rudolph, Christoph R. Hintschich · 2021 · Graefe s Archive for Clinical and Experimental Ophthalmology
53. Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy: success rate and predictive factors
    Mohammad Reza Akbari, Ahmad Ameri, Ali Reza Keshtkar Jaafari, Arash Mirmohammadsadeghi · 2016 · Journal of American Association for Pediatric Ophthalmology and Strabismus
54. Novel observational study protocol to develop a prediction model that identifies patients with Graves’ ophthalmopathy insensitive to intravenous glucocorticoids pulse therapy
    Yi Wang, Hui Wang, Lunhao Li, Yinwei Li, Jing Ping Sun, Xuefei Song, Huifang Zhou · 2021 · BMJ Open
55. Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression
    Nicola Currò, Claudio Guastella, Giacinta Pirola, Barbara Calonghi, Alessandra Bottari de Castello, Maria Chiara Fazio, Sabina di Benedetto, Valeria Minorini, Marco Daga, Andrea Contarino et al. · 2023 · Thyroid
56. Methylprednisolone and Hepatotoxicity in Graves' Ophthalmopathy
    Hanna Wichary, T Gasińska · 2011 · Thyroid
57. Statins May Increase the Risk of Liver Dysfunction in Patients Treated With Steroids for Active Graves' Orbitopathy
    Danila Covelli, Guia Maria Vannucchi, Irene Campi, Nicola Currò, Roberta D’Ambrosio, Marco Maggioni, Umberto Gianelli, Paolo Beck‐Peccoz, Mario Salvi · 2015 · The Journal of Clinical Endocrinology & Metabolism
58. Natural history of graves’ orbitopathy after treatment
    Francesca Menconi, Marenza Leo, Elena Sabini, Teresa Mautone, Marco Nardi, A. Sainato, Stefano Sellari‐Franceschini, Paolo Vitti, Claudio Marcocci, Michele Marinò · 2016 · Endocrine
59. Advances in the management of thyroid eye diseases: An overview
    Rashmi Kumari, Bhawesh Chandra Saha · 2017 · International Ophthalmology
60. Outcomes of endoscopic orbital decompression for graves’ ophthalmopathy
    Robbie Woods, Qistina Pilson, Natallia Kharytaniuk, Lorraine Cassidy, Rizwana Khan, Conrad V. I. Timon · 2019 · Irish Journal of Medical Science (1971 -)
61. Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease
    JaeSang Ko, Koung Hoon Kook, Jin Sook Yoon, Kyung In Woo, Jae Wook Yang · 2022 · BMJ Open
62. High neutrophil-to-lymphocyte ratio is associated with relapse in Graves’ disease after antithyroid drug therapy
    Mijin Kim, Bo Hyun Kim, Min Hee Jang, Jeong Mi Kim, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim · 2019 · Endocrine
63. Management of Moderately Severe Graves’Orbitopathy
    George Jean Kahaly · 2007 · KARGER eBooks
64. Efficacy and safety of combined parenteral and oral steroid therapy in Graves’ orbitopathy
    Biljana Nedeljkovic Beleslin, Jasmina Ćirić, Miloš Žarković, Mirjana Stojković, Slavica Savić, Miroslav Knežević, Branislav Stanković, Božo Trbojević · 2014 · HORMONES
65. Treatment options for Graves' orbitopathy
    Claudio Marcocci, Maria Antonietta Altea, Marenza Leo · 2012 · Expert Opinion on Pharmacotherapy
66. Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
    Rong-hua Song, Qian Li, Wen Wang, Qiuming Yao, Xiaoqing Shao, Jin‐an Zhang · 2017 · International Journal of Endocrinology
67. Multi-scale attention U-net for segmenting clinical target volume in graves’ ophthalmopathy
    Junjie Hu, Ying Song, Lei Zhang, Sen Bai, Yi Zhang · 2020 · Neurocomputing
68. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy
    Xing Wang, Shenglan Yang, Huijing Ye, Jingqiao Chen, Lu Shi, Lujia Feng, Xiandai Wang, Te Zhang, Rongxin Chen, Wei Xiao et al. · 2021 · Thyroid
69. Elevated percentage of HLA-DR+ and ICAM-1+ conjunctival epithelial cells in active Graves’ orbitopathy
    Przemysław Pawłowski, Janusz Myśliwiec, Małgorzata Mrugacz, Janusz Żak, Alina Bakunowicz‐Łazarczyk, Robert Ręjdak, Jolanta Wysocka, Magdalena Górska · 2014 · Graefe s Archive for Clinical and Experimental Ophthalmology
70. Graves orbitopathy: a perspective
    Petros Perros, Gerasimos E Krassas · 2009 · Nature Reviews Endocrinology
71. Diagnosis of Graves' Orbitopathy (DiaGO): Results of a Pilot Study to Assess the Utility of an Office Tool for Practicing Endocrinologists
    Anna Louise Mitchell, Linda Goss, Lemonia Mathiopoulou, Margaret Morris, Bijay Vaidya, A. Jane Dickinson, Anthony Quinn, Colin Mark Dayan, Julie McLaren, Janis L. Hickey et al. · 2014 · The Journal of Clinical Endocrinology & Metabolism
72. Visual changes after transnasal endoscopic versus transcaruncular medial orbital wall decompression for dysthyroid optic neuropathy
    Kunihiro Nishimura, Yasuhiro Takahashi, Nobuyuki Katahira, Yasue Uchida, Hiromi H. Ueda, Tetsuya Ogawa · 2019 · Auris Nasus Larynx
73. PPARg2 Ala12 variant protects against Graves' orbitopathy and modulates the course of the disease
    Edyta Pawlak, Jacek Daroszewski, Marek Bolanowski, Jolanta Oficjalska−Młyńczak, Przemysław Janusz, Marek Szaliñski, Irena Frydecka · 2013 · Immunogenetics
74. A Quantitative Method for Assessing the Degree of Axial Proptosis in Relation to Orbital Tissue Involvement in Graves' Orbitopathy
    Irene Campi, Guia Maria Vannucchi, Andrea Minetti, Davide Dazzi, Sabrina Avignone, Danila Covelli, Nicola Currò, Roberto Ratiglia, Claudio Guastella, Lorenzo Pignataro et al. · 2013 · Ophthalmology
75. Revision endoscopic orbital decompression in the management of Graves' orbitopathy
    Man‐Kit Leung, Michael P. Platt, Ralph B. Metson · 2009 · Otolaryngology
76. Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy
    Edmunds, Matthew R., Mellington, Faye, Ford, Rebecca L., Torlinska, Barbara, Manavi, Kaveh, Boelaert, Kristien · 2015 · The Journal of Clinical Endocrinology & Metabolism
77. Non-Oncological Radiotherapy: A Review of Modern Approaches
    Valerio Nardone, Emma D’Ippolito, Roberta Grassi, Angelo Sangiovanni, Federico Gagliardi, Giuseppina De Marco, Vittorio Salvatore Menditti, Luca D’Ambrosio, Fabrizio Cioce, Luca Boldrini et al. · 2022 · Journal of Personalized Medicine
78. Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
    Jungyul Park, Jae Hyun Kim, Sang Soo Kim, Hee-Young Choi · 2023 · Frontiers in Endocrinology
79. Reduced choroidal peripapillary capillaries in thyroid-associated ophthalmopathy with early stage of dysthyroid optic neuropathy
    Jiahui Wu, Hao Zhou, Ying Wu, Jian Zhang, Jin-Wei Cheng · 2022 · International Journal of Ophthalmology
80. Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes
    Nisar Sonam Poonam, Md. Shahid Alam, Prashant Oberoi, Bipasha Mukherjee · 2022 · Indian Journal of Ophthalmology
81. Orbit and Orbital Apex
    Dan Robinson, Geoff Wilcsek, Raymond Sacks · 2011 · Otolaryngologic Clinics of North America
82. Qualitative and Quantitative Impact of Protective Glucocorticoid Therapy on the Effective 131I Half-Life in Radioiodine Therapy for Graves Disease
    Hubertus Hautzel, Elisabeth Pisar, Nahid Yazdan-Doust, Matthias Schott, Markus Beu, Hans‐Wilhelm Müller · 2010 · Journal of Nuclear Medicine
83. The early diagnostic value of optical coherence tomography (OCT) and OCT angiography in thyroid-associated ophthalmopathy
    Bei Xu, Sha Wang, Lu Chen, Jia Tan · 2023 · Therapeutic Advances in Chronic Disease
84. Variables Affecting the Long-Term Outcome of Graves Orbitopathy Following High-Dose Intravenous Glucocorticoid Pulse Therapy in Patients not Treated with Orbital Radiotherapy
    Marenza Leo, Teresa Mautone, Ilaria Ionni, Maria Antonietta Profilo, Elena Sabini, Francesca Menconi, Barbara Mazzi, Roberto Rocchi, Francesco Latrofa, Marco Nardi et al. · 2016 · Endocrine Practice
85. Meibomian glands dropout in patients with inactive thyroid related orbitopathy
    Vannarut Satitpitakul, Tanavadee Rattanaphong, Vannakorn Pruksakorn · 2021 · PLoS ONE
86. Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves’ Orbitopathy
    Chao Ma, Haoyu Li, Wei Liu, Shuwen Lu, Xian Li, Jinyuan Chen, Kaijun Li, Wenzhan Wang · 2022 · Journal of Immunology Research
87. Tocilizumab for thyroid eye disease
    Shirin Hamed Azzam, Swan Kang, Mario Salvi, Daniel G. Ezra · 2018 · Cochrane Database of Systematic Reviews
88. Novel immunoinflammatory blood markers in Graves’ orbitopathy: insights into activity and severity
    Mahdi Abounoori, Mohsen Pourazizi, Mohsen Bahmani Kashkouli, Ozra Akha, Reza Jafari, Marzieh Movahedirad · 2024 · BMJ Open Ophthalmology
89. Clinical relevance of T lymphocyte subsets in pediatric Graves’ disease
    Ting Chen, Linqi Chen, Haojie Song, Xiuli Chen, Rongrong Xie, Xia Qin, Dandan Zhang, Haiying Wu, Hui Sun, Xiaoyan Wang et al. · 2020 · Journal of Pediatric Endocrinology and Metabolism
90. Leptin receptor is a key gene involved in the immunopathogenesis of thyroid‐associated ophthalmopathy
    Ziyi Chen, Zhe Chen, Jingya Wang, Meng Zhang, Xiaofei Wang, Deji Cuomu, Bingyin Shi, Yue Wang · 2021 · Journal of Cellular and Molecular Medicine
91. Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves’ Orbitopathy
    Xing Wang, Huijing Ye, Shenglan Yang, Xiaotong Sha, Xiandai Wang, Te Zhang, Rongxin Chen, Wei Xiao, Huasheng Yang · 2022 · International Journal of Molecular Sciences
92. Radioiodine Ablation of Thyroid Remnants in Patients with Graves’ Orbitopathy
    Michael Oeverhaus, J. Koenen, Nikolaos Emmanouel Bechrakis, Mareile Stöhr, Ken Herrmann, Wolfgang P. Fendler, Anja Katrin Eckstein, Manuel Weber · 2022 · Journal of Nuclear Medicine
93. Graves’ hyperthyroidism of recent onset and Graves’ orbitopathy: To ablate or not to ablate the thyroid?
    Luigi Bartalena, Claudio Marcocci, Adriana Lai, Maria Laura Tanda · 2008 · Journal of Endocrinological Investigation
94. Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy
    Hélio Amante Miot, Leonardo Parr dos Santos Fernandes, Edson Nacib Jorge, Daniel Rosito Pivotto, Célia Regina Nogueira, Gláucia Maria Ferreira da Silva Mazeto · 2009 · Clinics
95. Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent
    Suryasnata Rath, Anuradha Pradhan, Anasua Ganguly, MilindN Naik, AkshayGopinathan Nair, Savari Desai · 2020 · Indian Journal of Ophthalmology
96. Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT
    Chiara Del Noce, Matilde Roda, Lorenzo Ferro Desideri, Carlo Enrico Traverso, Aldo Vagge · 2021 · Graefe s Archive for Clinical and Experimental Ophthalmology
97. Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions
    Irene Campi, Nicola Currò, Guia Maria Vannucchi, Danila Covelli, Simona Simonetta, Laura Fugazzola, Davide Dazzi, Lorenzo Pignataro, Claudio Guastella, Elisa Lazzaroni et al. · 2020 · Thyroid
98. Comparison of 2-wall versus 3-wall orbital decompression against dysthyroid optic neuropathy in visual function
    Shengnan Cheng, Yue-Qi Yu, Yayan You, Jin Chen, Xiaohuan Pi, Xinghua Wang, Fagang Jiang · 2021 · Medicine
99. Teprotumumab and Orbital Decompression for the Management of Proptosis in Patients With Thyroid Eye Disease
    Sasha Hubschman, Badal Sojitra, Sean Ghiam, Connie Martin Sears, Nathan Hwangbo, Robert A. Goldberg, Daniel B. Rootman · 2023 · Ophthalmic Plastic and Reconstructive Surgery
100. The Relationship between Obesity-Related Factors and Graves’ Orbitopathy: A Pilot Study
     Ching Lu, Chao‐Lun Lai, Chih‐Man Yang, Karen Chia-Wen Liao, Chie-Shung Kao, Tien-Chu Chang, Ming‐Der Perng · 2022 · Medicina